CN111838824A - Antifog gauze mask of separation germ - Google Patents

Antifog gauze mask of separation germ Download PDF

Info

Publication number
CN111838824A
CN111838824A CN202010833814.9A CN202010833814A CN111838824A CN 111838824 A CN111838824 A CN 111838824A CN 202010833814 A CN202010833814 A CN 202010833814A CN 111838824 A CN111838824 A CN 111838824A
Authority
CN
China
Prior art keywords
solution
woven fabric
layer
fabric layer
gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010833814.9A
Other languages
Chinese (zh)
Inventor
卢亢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Taibao Medical Science Technology Co Ltd
Original Assignee
Guangdong Taibao Medical Science Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Taibao Medical Science Technology Co Ltd filed Critical Guangdong Taibao Medical Science Technology Co Ltd
Priority to CN202010833814.9A priority Critical patent/CN111838824A/en
Publication of CN111838824A publication Critical patent/CN111838824A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/04Materials specially adapted for outerwear characterised by special function or use
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/04Materials specially adapted for outerwear characterised by special function or use
    • A41D31/12Hygroscopic; Water retaining
    • A41D31/125Moisture handling or wicking function through layered materials
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/04Materials specially adapted for outerwear characterised by special function or use
    • A41D31/30Antimicrobial, e.g. antibacterial
    • A41D31/305Antimicrobial, e.g. antibacterial using layered materials

Landscapes

  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention provides an anti-fog mask for obstructing germs, which is of a laminated structure and sequentially comprises the following components from outside to inside: the first non-woven fabric layer, the disease-resistant bacterium layer and the second non-woven fabric layer; the first non-woven fabric layer is an outer-layer non-woven fabric with the surface subjected to hydrophobic modification, and the disease-resistant layer is composed of polypropylene fibers and an antibacterial gelatin composite material, wherein the polypropylene fibers account for 85-95 parts by weight, and the antibacterial gelatin composite material accounts for 5-15 parts by weight. On one hand, the mask prepared by the invention has the effect of preventing water mist; on the other hand, the filter has good filtering effect on pathogenic bacteria, and the experimental result shows that the filtering effect on staphylococcus aureus can reach more than 97%.

Description

Antifog gauze mask of separation germ
Technical Field
The invention belongs to the technical field of medical sanitary materials, particularly relates to a mask, and particularly relates to an anti-fog mask capable of blocking germs.
Background
Since 2020, new coronaviruses have gradually exploded worldwide, driving the sensitive nerves of the world. People pay more attention to the cognition of the mask under the continuous call of medical professionals. The mask is a medical sanitary material product, and is a tool which is covered on the mouth and nose parts of a wearer and is used for preventing dust, harmful gas, smell and droplet viruses from entering and exiting the mouth and nose of the wearer. The mask has a good effect when the respiratory infectious disease is epidemic and the mask is worn when the mask is operated in the environment polluted by dust and the like. Today, with the continued fermentation of the novel coronavirus (COVID-19), there is an increasing demand for masks that prevent the transmission of the virus through the respiratory tract.
Generally, most viruses are about 10nm to 300nm in size, while the novel coronavirus of this epidemic (COVID-19) is about 125nm in size. At present, although the mask plays a good role in blocking germs and preventing cross infection. However, even the N95 mask promoted by the World Health Organization (WHO) currently can block particles only about 300nm, so that most viruses including the COVID-19 cannot be completely blocked from entering the mouth and nose of the wearer. Therefore, the development of a novel composite material capable of efficiently blocking germs as a filter layer of an epidemic prevention mask is the key for effectively preventing viruses from spreading.
Disclosure of Invention
The invention aims to provide an anti-fog mask for obstructing germs to solve the problems in the prior art, and the invention is realized by the following technical scheme to solve the technical problems:
the utility model provides an antifog gauze mask of separation germ, is laminated structure, outside-in includes in proper order: the first non-woven fabric layer, the disease-resistant bacterium layer and the second non-woven fabric layer; the disease-resistant layer is composed of polypropylene fibers and an antibacterial gelatin composite material, and the first non-woven fabric layer is an outer non-woven fabric with the surface subjected to hydrophobic modification.
Wherein, the polypropylene fiber accounts for 85 to 95 weight portions, and the antibacterial gelatin composite material accounts for 5 to 15 weight portions; the preparation process of the antibacterial gelatin composite material comprises the following steps:
s1: dissolving cannabidiol in a volume ethanol-water solution to prepare a cannabidiol solution with the mass concentration of 2-5%, blending and stirring the cannabidiol solution and a glycerol isostearate water solution with the mass concentration of 5-10% at 65-75 ℃ for 30-60 min, adding carboxymethyl cellulose with the mass of 20-30% of the blending solution, and performing ultrasonic treatment for 30min to obtain a mixed solution A;
s2: preparing a gelatin aqueous solution with the mass concentration of 10%, adding hydroxypropyl guar gum accounting for 2-8% of the dry weight of the gelatin, stirring at room temperature for 40-60 min, then blending the mixture with the mixed solution A in an equal volume, stirring at room temperature for 60-80 min, and adjusting the pH value of the mixed solution to 7-9 to obtain a mixed solution B;
s3: and (3) fully mixing the cyanidin-3-rutinoside solution, the lysine solution and the mixed solution B with the same volume, continuously stirring at room temperature for 40-60 min, and finally injecting the mixture into a mold for drying to obtain the antibacterial gelatin composite material.
Preferably, the volume ratio of the cannabidiol solution to the glyceryl isostearate aqueous solution in the step (1) is 1: (1-2);
preferably, in the step (3), the mass fraction of the cyanidin-3-rutinoside solution is 2-5%, and the mass fraction of the lysine solution is 6-10%.
Preferably, the first non-woven fabric layer and the second non-woven fabric layer are made of one or more of chitosan fibers, activated carbon fibers and polypropylene fibers.
Preferably, the hydrophobic modification process of the surface of the first nonwoven fabric layer is as follows: adding 0.1-1 g of acrylamide and 0.001-0.005 g of potassium persulfate into a gelatin aqueous solution containing 5g of gelatin, adding a first nonwoven fabric, continuously stirring, and reacting for 0.5-5 h.
Furthermore, a phase change fiber material layer is arranged between the disease bacterium blocking layer and the second non-woven fabric layer.
Preferably, the volume ratio of the ethanol-water solution in the step (1) is 1: 1 to 1.5.
The invention has at least the following beneficial effects:
(1) hydroxyl on cyanidin-3-rutinoside is combined with carbonyl on lysine to form hydrogen bond, and amino on lysine is protected, so that the material has good effect of inhibiting germs;
(2) cannabidiol which is a natural plant extract is introduced into gelatin to enhance the stability of the gelatin, and two hydroxyl groups are arranged at two molecular ends of the cannabidiol, so that the cannabidiol can generate a conjugated effect of electron cloud deviation under an alkaline condition to further promote the cannabidiol to better exert the anti-inflammatory and antibacterial effects of the cannabidiol, and the antibacterial effect of the material is further enhanced under the combined action of the dual antibacterial factors;
(3) the hydroxyl between the carboxymethyl cellulose of the hydrophilic material and cyanidin-3-rutinoside molecules forms a strong hydrogen bond, which is beneficial to the material to form a whole, so that the mechanical property of the composite material is enhanced, and the material performance is more stable; on the other hand, the material can be endowed with a certain moisture absorption effect, so that a microenvironment which is beneficial to blocking and inhibiting the propagation or penetration of pathogenic bacteria is formed, and a wearer is effectively protected from the invasion of pathogenic bacteria. The phase change fiber material layer can absorb moisture and absorb heat.
(4) The invention aims at the surface hydrophobic modification of the non-woven fabric on the outer layer of the mask, and is mainly based on a large amount of tight hydrogen bonds generated between acrylamide and gelatin chain bonds, so that the gelatin chain is attached to a section of hydrophobic chain, gelatin is attached to the non-woven fabric on the outer layer, the hydrophobicity of the gelatin is greatly enhanced, and the convection between water vapor in the middle layer and the outside air is smoother, so that the wettability is reduced when the water vapor in the middle layer is saturated, the generation of mist is further prevented, particularly, the visual obstruction caused when a spectacle wearer wears the mask can be prevented, and the wearing comfort of the spectacle wearer is enhanced.
Detailed Description
The following provides examples of the present invention, and the present invention will be specifically described by way of examples. It should be noted that the examples are given solely for the purpose of illustration and are not to be construed as limitations on the scope of the invention, as many insubstantial modifications and variations of the invention may be made by those skilled in the art in light of the teachings herein.
Preparative example 1:
the preparation process of the gelatin composite film comprises the following steps:
(1) dissolving cannabidiol in a volume ratio of 1: 1, preparing a cannabidiol solution with the mass concentration of 4% in an ethanol-water solution, blending and stirring the cannabidiol solution with a glycerol isostearate water solution with the mass concentration of 5% at the temperature of 75 ℃ for 30min, adding carboxymethyl cellulose with the mass concentration of 20% in the blending solution, and performing ultrasonic treatment for 30min to obtain a mixed solution A;
(2) preparing a gelatin aqueous solution with the mass concentration of 10%, adding hydroxypropyl guar gum accounting for 4% of the dry weight of the gelatin, stirring for 50min at room temperature, blending the mixture with the mixed solution A in the same volume, stirring for 60min at room temperature, and adjusting the pH value of the mixed solution to X to obtain a mixed solution B;
(3) and (3) fully mixing the cyanidin-3-rutinoside solution, the lysine solution and the mixed solution B with the same volume, continuously stirring at room temperature for 40min, and finally injecting the mixture into a mold to dry to obtain the antibacterial gelatin composite material.
Wherein:
step (1): the volume ratio of the cannabidiol solution to the glyceryl isostearate aqueous solution is 1: 1;
and (3): the mass fraction of the cyanidin-3-rutinoside solution is 5%, and the mass fraction of the lysine solution is 10%.
And (3) determining the antibacterial effect: the effect test of the invention selects the escherichia coli as a sterilization object and studies the antibacterial performance of the escherichia coli by a bacteriostatic zone test method. The size of the inhibition zone around the sample is measured by a meter ruler, in order to ensure the accuracy of data, the width of the inhibition zone of each sample is measured for 6 times in different directions at intervals of 60 degrees, and the size of the inhibition zone is the average value of the widths of the inhibition zones of the samples and the size of the measured inhibition zone. A piece of white paper of the same size was selected as a blank control.
For accurate measurement, three groups of samples were cultured in parallel for each group of samples, and the average values of the three groups of samples were measured again, and the test results of the final average values obtained are shown in table 1.
TABLE 1 inhibition zone size of gelatin composite membrane samples prepared at different pH values for Escherichia coli
pH value (X) 6 6.5 7 7.5 8 8.5 9 9.5 10 Blank space
Size of bacteriostatic circle (mm) 9 11 22 21 23 22 24 20 19 1
From the results shown in table 1, when the pH of the mixed solution in step (2) is greater than 9, the bacteriostatic ability of the gelatin composite membrane to escherichia coli is gradually reduced, and when the pH is less than 7, the bacteriostatic ability of the gelatin composite membrane is general. When the pH value is 7-9, namely under a proper alkaline condition, because two hydroxyl groups are arranged at two ends of a molecule of the cannabidiol, the hydroxyl groups can generate a conjugated effect of electron cloud deviation, and further the hydroxyl groups can better play an antibacterial and antibacterial effect.
Preparative example 2:
the cyanidin-3-rutinoside solution in step (3) of preparative example 1 was directly removed, or tea polyphenol, dialdehyde xanthan gum, genipin and tannic acid were used instead, the pH in step (2) was 7, the other conditions were exactly the same as those in preparative example 1, and the prepared gelatin composite membrane was tested for its bacteriostatic activity against escherichia coli in the same manner as described above, and the results are shown in table 2 below.
Preparatory example 3:
the carboxymethyl cellulose solution of step (1) of preparative example 1 was removed, the pH of step (2) was 7, and the conditions were completely the same as those of preparative example 1, and the gelatin composite membrane was prepared and tested for its bacteriostatic activity against e.coli in the same manner as described above, and the results are shown in table 2 below.
TABLE 2 inhibition zone size of gelatin composite membrane samples prepared under different conditions for Escherichia coli
Figure BDA0002638955560000041
As can be seen from the table above, the substitution of other cross-linking agents for the 3-rutinoside has a significant reduction in the bacteriostatic effect on Escherichia coli, and the presence or absence of carboxymethyl cellulose in the preparation conditions has a certain effect on the bacteriostatic ability. This is mainly due to cyanidin-3-rutinoside: on one hand, hydroxyl in the molecular structure of the material is combined with carbonyl on lysine to form a hydrogen bond, and meanwhile, amino on the lysine is protected, so that the material has a good effect of inhibiting germs; on the other hand, the hydroxyl between the carboxymethyl cellulose of the hydrophilic material and cyanidin-3-rutinoside molecules forms a strong hydrogen bond, which is beneficial to the material to form a whole, so that the mechanical property of the composite material is enhanced, and the performance of the material is more stable; and the carboxymethyl cellulose can endow the material with a certain moisture absorption effect, so that a microenvironment which is favorable for obstructing and inhibiting the propagation or penetration of pathogenic bacteria is formed, and a wearer is effectively protected from the invasion of pathogenic bacteria.
Preparatory example 4: hydrophobicity test
Before and after the outer-layer non-woven fabric is subjected to hydrophobic modification (wherein the outer-layer non-woven fabric adopts polypropylene fibers), the respective surface materials are subjected to hydrophobic experiments, and the results are as follows:
table 3 hydrophobicity test results of different materials
Figure BDA0002638955560000051
From the results of the above table, it can be seen that the hydrophobic modification effect of the present invention on the outer layer nonwoven fabric is significant.
Example 1
The utility model provides an antifog gauze mask of separation germ, is laminated structure, outside-in includes in proper order: the first non-woven fabric layer, the disease-resistant bacterium layer and the second non-woven fabric layer; the disease-resistant layer is composed of 85 parts by weight of polypropylene fiber and 15 parts by weight of antibacterial gelatin composite material;
the preparation process of the antibacterial gelatin composite material comprises the following steps:
(1) dissolving cannabidiol in a volume ratio of 1: 1, preparing a cannabidiol solution with the mass concentration of 4% in an ethanol-water solution, blending and stirring the cannabidiol solution with a glycerol isostearate water solution with the mass concentration of 5% at 75 ℃ for 30min, adding carboxymethyl cellulose with the mass concentration of 20% in the blending solution, and performing ultrasonic treatment for 30min to obtain a mixed solution A;
(2) preparing a gelatin aqueous solution with the mass concentration of 10%, adding hydroxypropyl guar gum accounting for 4% of the dry weight of the gelatin, stirring for 50min at room temperature, blending the mixture with the mixed solution A in the same volume, stirring for 60min at room temperature, and adjusting the pH value of the mixed solution to 7 to obtain a mixed solution B;
(3) and (3) fully mixing the cyanidin-3-rutinoside solution, the lysine solution and the mixed solution B with the same volume, continuously stirring at room temperature for 40min, and finally injecting the mixture into a mold to dry to obtain the antibacterial gelatin composite material.
Wherein: in the step (1), the volume ratio of the cannabidiol solution to the glyceryl isostearate aqueous solution is 1: 1; in the step (3), the mass fraction of the cyanidin-3-rutinoside solution is 3%, and the mass fraction of the lysine solution is 6%.
The first non-woven fabric layer and the second non-woven fabric layer are both made of chitosan fibers.
A phase-change fiber material layer is also arranged between the disease-resistant bacteria blocking layer and the second non-woven fabric layer. The hydrophobic modification process of the surface of the first non-woven fabric layer comprises the following steps: adding 0.1g of acrylamide and 0.001g of potassium persulfate into a gelatin aqueous solution containing 5g of gelatin, adding a first nonwoven fabric, continuously stirring, and reacting for 0.5 h.
Example 2
The utility model provides an antifog gauze mask of separation germ, is laminated structure, outside-in includes in proper order: the first non-woven fabric layer, the disease-resistant bacterium layer and the second non-woven fabric layer; the disease-resistant layer is composed of 90 parts by weight of polypropylene fiber and 10 parts by weight of antibacterial gelatin composite material;
the preparation process of the antibacterial gelatin composite material comprises the following steps:
(1) dissolving cannabidiol in a volume ratio of 1: 1.5, preparing a cannabidiol solution with the mass concentration of 2% in an ethanol-water solution, blending and stirring the cannabidiol solution with a glycerol isostearate water solution with the mass concentration of 6% for 50min at the temperature of 65 ℃, adding carboxymethyl cellulose with the mass of 30% of the blended solution, and performing ultrasonic treatment for 30min to obtain a mixed solution A;
(2) preparing a gelatin aqueous solution with the mass concentration of 10%, adding hydroxypropyl guar gum accounting for 2% of the dry weight of the gelatin, stirring for 45min at room temperature, blending the mixture with the mixed solution A in the same volume, stirring for 75min at room temperature, and adjusting the pH value of the mixed solution to 8 to obtain a mixed solution B;
(3) and (3) fully mixing the cyanidin-3-rutinoside solution, the lysine solution and the mixed solution B with equal volumes, continuously stirring for 45min at room temperature, and finally injecting the mixture into a mould to dry to obtain the antibacterial gelatin composite material.
Wherein: in the step (1), the volume ratio of the cannabidiol solution to the glyceryl isostearate aqueous solution is 1: 2; in the step (3), the mass fraction of the cyanidin-3-rutinoside solution is 2%, and the mass fraction of the lysine solution is 7%.
The first non-woven fabric layer is made of activated carbon fibers, and the second non-woven fabric layer is made of chitosan fibers. The hydrophobic modification process of the surface of the first non-woven fabric layer comprises the following steps: adding 1.0g of acrylamide and 0.005g of potassium persulfate into a gelatin aqueous solution containing 5g of gelatin, adding a first nonwoven fabric, continuously stirring, and reacting for 5 hours.
A phase-change fiber material layer is also arranged between the disease-resistant bacteria blocking layer and the second non-woven fabric layer.
Example 3
The utility model provides an antifog gauze mask of separation germ, is laminated structure, outside-in includes in proper order: the first non-woven fabric layer, the disease-resistant bacterium layer and the second non-woven fabric layer; the disease-resistant layer is composed of polypropylene fibers and an antibacterial gelatin composite material, wherein the polypropylene fibers account for 92 parts by weight, and the antibacterial gelatin composite material accounts for 8 parts by weight;
the preparation process of the antibacterial gelatin composite material comprises the following steps:
(1) dissolving cannabidiol in a volume ratio of 1: 1.2, preparing a 3% cannabidiol solution in mass concentration in an ethanol-water solution, blending and stirring the cannabidiol solution in a 10% glycerol isostearate water solution at 70 ℃ for 50min, adding 25% carboxymethylcellulose in mass of the blending solution, and performing ultrasonic treatment for 30min to obtain a mixed solution A;
(2) preparing a gelatin aqueous solution with the mass concentration of 10%, adding hydroxypropyl guar gum accounting for 8% of the dry weight of the gelatin, stirring at room temperature for 40min, then blending the mixture with the mixed solution A in the same volume, stirring at room temperature for 70min, and adjusting the pH value of the mixed solution to 7.5 to obtain a mixed solution B;
(3) and (3) fully mixing the cyanidin-3-rutinoside solution, the lysine solution and the mixed solution B which have the same volume, continuously stirring for 50min at room temperature, and finally injecting the mixture into a mould to dry to obtain the antibacterial gelatin composite material.
Wherein: in the step (1), the volume ratio of the cannabidiol solution to the glyceryl isostearate aqueous solution is 1: 1.5; in the step (3), the mass fraction of the cyanidin-3-rutinoside solution is 5%, and the mass fraction of the lysine solution is 8%.
The first non-woven fabric layer and the second non-woven fabric layer are both made of polypropylene fibers. The hydrophobic modification process of the surface of the first non-woven fabric layer comprises the following steps: adding 0.5g of acrylamide and 0.004g of potassium persulfate into a gelatin aqueous solution containing 5g of gelatin, adding a first nonwoven fabric, continuously stirring, and reacting for 2 hours.
A phase-change fiber material layer is also arranged between the disease-resistant bacteria blocking layer and the second non-woven fabric layer.
Example 4
The utility model provides an antifog gauze mask of separation germ, is laminated structure, outside-in includes in proper order: the first non-woven fabric layer, the disease-resistant bacterium layer and the second non-woven fabric layer; the disease-resistant layer is composed of 95 parts by weight of polypropylene fiber and 5 parts by weight of antibacterial gelatin composite material;
the preparation process of the antibacterial gelatin composite material comprises the following steps:
(1) dissolving cannabidiol in a volume ratio of 1: 1.3, preparing a cannabidiol solution with the mass concentration of 5% in an ethanol-water solution, blending and stirring the cannabidiol solution with a glycerol isostearate water solution with the mass concentration of 8% at 65 ℃ for 60min, adding carboxymethyl cellulose with the mass of 28% of the blending solution, and performing ultrasonic treatment for 30min to obtain a mixed solution A;
(2) preparing a gelatin aqueous solution with the mass concentration of 10%, adding hydroxypropyl guar gum accounting for 6% of the dry weight of the gelatin, stirring at room temperature for 60min, then blending the mixture with the mixed solution A in the same volume, stirring at room temperature for 80min, and adjusting the pH value of the mixed solution to 9 to obtain a mixed solution B;
(3) and (3) fully mixing the cyanidin-3-rutinoside solution, the lysine solution and the mixed solution B with the same volume, continuously stirring at room temperature for 60min, and finally injecting the mixture into a mold for drying to obtain the antibacterial gelatin composite material.
Wherein: in the step (1), the volume ratio of the cannabidiol solution to the glyceryl isostearate aqueous solution is 1: 1.2; in the step (3), the mass fraction of the cyanidin-3-rutinoside solution is 4%, and the mass fraction of the lysine solution is 10%.
The first non-woven fabric layer and the second non-woven fabric layer are both formed by compounding activated carbon fibers and polypropylene fibers. The hydrophobic modification process of the surface of the first non-woven fabric layer comprises the following steps: adding 0.8g of acrylamide and 0.003g of potassium persulfate into a gelatin aqueous solution containing 5g of gelatin, adding a first nonwoven fabric, continuously stirring, and reacting for 3 hours.
A phase-change fiber material layer is also arranged between the disease-resistant bacteria blocking layer and the second non-woven fabric layer.
Example 5 mask filtration efficiency test for bacteria
The barrier effect of the mask in the above embodiments 1 to 4 on germs is characterized by the bacteria filtration efficiency (the selected bacteria is golden yellow), and the specific detection steps are as follows:
(1) a24 h fresh culture broth of Staphylococcus aureus was taken and diluted with phosphate buffer containing peptone to prepare a bacterial suspension at the test concentration for use. Before the test, the mask sample is placed in an environment with the temperature of (21 +/-5) DEG C and the relative humidity of (85 +/-5)% for pretreatment for at least 4 h;
(2) the aerosol generator is connected with a peristaltic pump and an air source, the spray nozzle of the generator is connected with the air inlet of a pipeline, and the pipeline is provided with two sampling ports. One sampling port is connected with the testing mask and is used as an experimental group after being sampled by an air microorganism sampler; the other sampling port is not provided with a mask, and the other sampling port is directly used as positive quality control after being sampled by an air microorganism sampler.
(3) Placing the bacterial suspension in a bacterial liquid bottle of an aerosol generator, starting the aerosol generator, and spraying at a flow rate of 5L/min and a spraying pressure of 1.8kg/cm2Spraying aerosol for 1min, loading a sampling plate with diameter of 90mm into a six-stage sampler, sampling the sample of the test mask for 2min at sampling flow of 28.3L/min, and collecting positive samplesSampling for 1 min. Calculating the average particle diameter (MPS) of the bacterial aerosol to be (3.0 +/-0.3) mu m, and the geometric standard deviation of the distribution of the bacterial aerosol to be not more than 1.5;
(4) putting the sampling plates into a 37C incubator for culturing for 48h, counting the colony count (cfu) of each sampling plate, enabling the results of the 4 th and 5 th sampling grades to meet the particle size requirement in the standard, correcting by using a correction table, and converting the concentration of the bacterial aerosol into cfu/m3And calculating the filtering efficiency according to the concentrations of the bacterial aerosol before and after filtering. The formula for calculating the filtering efficiency of the mask bacteria is BFE (C-T)/C multiplied by 100% (wherein C is the positive quality control aerosol concentration, and T is the aerosol concentration of the test sample).
And common medical surgical mask products on the market are selected as a contrast, and the results are shown in table 3:
TABLE 3 Filtering Effect of different mask samples
Test specimen Filtering effect
Example 1 97.5%
Example 2 98.5%
Example 3 99.0%
Example 4 96.5%
Medical surgery gauze mask sold in market (Yubei defending material) 91.5%
From the results in table 3, it can be seen that, compared with the common medical surgical mask produced by the material used in north Henan province, the mask manufactured under the condition of the present invention has a significantly improved filtering effect on germs, which reaches more than 97%, and has significant progress.
It should be understood that the present invention is not limited to the above-described embodiments. The above-described embodiments are examples, and all inventions having substantially the same configuration as the technical idea described in the claims of the present invention and exhibiting the same operation and effect are included in the technical scope of the present invention.

Claims (7)

1. The utility model provides an antifog gauze mask of separation germ which characterized in that for laminated structure, outside-in includes in proper order: the first non-woven fabric layer, the disease-resistant bacterium layer and the second non-woven fabric layer; the disease-resistant layer is made of polypropylene fiber and antibacterial gelatin composite material, and the first non-woven fabric layer is outer non-woven fabric with the surface subjected to hydrophobic modification;
wherein, the polypropylene fiber accounts for 85 to 95 weight portions, and the antibacterial gelatin composite material accounts for 5 to 15 weight portions; the preparation process of the antibacterial gelatin composite material comprises the following steps:
(1) dissolving cannabidiol in an ethanol-water solution to prepare a cannabidiol solution with the mass concentration of 2-5%, blending and stirring the cannabidiol solution and a glycerol isostearate water solution with the mass concentration of 5-10% at 65-75 ℃ for 30-60 min, adding carboxymethyl cellulose with the mass of 20-30% of the blending solution, and performing ultrasonic treatment for 30min to obtain a mixed solution A;
(2) preparing a gelatin aqueous solution with the mass concentration of 10%, adding hydroxypropyl guar gum accounting for 2-8% of the dry weight of the gelatin, stirring at room temperature for 40-60 min, then blending the mixture with the mixed solution A in an equal volume, stirring at room temperature for 60-80 min, and adjusting the pH value of the mixed solution to 7-9 to obtain a mixed solution B;
(3) and (3) fully mixing the cyanidin-3-rutinoside solution, the lysine solution and the mixed solution B with the same volume, continuously stirring at room temperature for 40-60 min, and finally injecting the mixture into a mold for drying to obtain the antibacterial gelatin composite material.
2. The anti-fog mask with the function of obstructing germs according to claim 1, wherein the volume ratio of the cannabidiol solution to the glyceryl isostearate solution in the step (1) is 1: (1-2).
3. The anti-fog mask with the function of obstructing germs according to claim 1, wherein the mass fraction of the cyanidin-3-rutinoside solution in the step (3) is 2-5%, and the mass fraction of the lysine solution is 6-10%.
4. The anti-fog mask with the function of obstructing germs as claimed in claim 1, wherein the first non-woven fabric layer and the second non-woven fabric layer are made of one or more of chitosan fiber, activated carbon fiber and polypropylene fiber.
5. The anti-fog mask with the function of obstructing germs as claimed in claim 1, wherein the hydrophobic modification process of the surface of the first non-woven fabric layer is as follows: adding 0.1-1 g of acrylamide and 0.001-0.005 g of potassium persulfate into a gelatin aqueous solution containing 5g of gelatin, adding a first nonwoven fabric, continuously stirring, and reacting for 0.5-5 h.
6. The anti-fog mask with the function of obstructing germs according to claim 1, wherein a phase-change fiber material layer is further arranged between the disease-obstructing bacteria layer and the second non-woven fabric layer.
7. The anti-fog mask with the function of obstructing germs according to claim 1, wherein the volume ratio of the ethanol-water solution in the step (1) is 1: 1 to 1.5.
CN202010833814.9A 2020-08-18 2020-08-18 Antifog gauze mask of separation germ Pending CN111838824A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010833814.9A CN111838824A (en) 2020-08-18 2020-08-18 Antifog gauze mask of separation germ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010833814.9A CN111838824A (en) 2020-08-18 2020-08-18 Antifog gauze mask of separation germ

Publications (1)

Publication Number Publication Date
CN111838824A true CN111838824A (en) 2020-10-30

Family

ID=72969239

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010833814.9A Pending CN111838824A (en) 2020-08-18 2020-08-18 Antifog gauze mask of separation germ

Country Status (1)

Country Link
CN (1) CN111838824A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107981441A (en) * 2017-12-10 2018-05-04 余沛阳 A kind of Medical efficient bactericidal mask
CN109517309A (en) * 2018-11-09 2019-03-26 福建农林大学 A kind of preparation method of plant polyphenol nano-cellulose antibacterial self-healing hydrogel
CN111535037A (en) * 2020-05-07 2020-08-14 闽江学院 Preparation method of antibacterial fabric, antibacterial fabric and mask

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107981441A (en) * 2017-12-10 2018-05-04 余沛阳 A kind of Medical efficient bactericidal mask
CN109517309A (en) * 2018-11-09 2019-03-26 福建农林大学 A kind of preparation method of plant polyphenol nano-cellulose antibacterial self-healing hydrogel
CN111535037A (en) * 2020-05-07 2020-08-14 闽江学院 Preparation method of antibacterial fabric, antibacterial fabric and mask

Similar Documents

Publication Publication Date Title
CN110041764A (en) A kind of liquid mask patch and anti-haze antibacterial mask
CN112220799A (en) Product for inhibiting virus and application
CN108743702A (en) A kind of anti-haze poison spray and preparation method thereof
CN111514479A (en) Microorganism disinfection type silver-carrying mask
CN107051232A (en) One kind sterilization removes aldehyde air-filtering membrane
CN111235871A (en) Antiviral filter layer prepared from copper-containing chitosan fiber and application thereof
CN111838824A (en) Antifog gauze mask of separation germ
CN112641147A (en) Recyclable mask, preparation method and recycling method
CN111938235A (en) High-efficient separation germ gauze mask
CN111714455A (en) Quaternary ammonium salinization chitin anti-pathogenic microorganism spray, preparation method and application thereof
Liang et al. Pump-inject antimicrobial and biodegradable aerogel as mask intermediate filter layer for medical protection of air filtration
CN107616960B (en) Biological sterilization hand sanitizer and production process thereof
CN113069556B (en) Oxidized alginic acid fiber membrane of cladinostat and preparation method thereof
CN205757364U (en) A kind of gauze mask
CN105664224B (en) A kind of compound alginic acid dressing of low molecular weight carboxymethyl chitosan and preparation method thereof
CN105126149B (en) A kind of medical recombination chitosan application
CN112120318B (en) Antiviral gauze mask of wood juice
CN114190632A (en) Antibacterial breathable mask and preparation method thereof
CN113684681A (en) Mask preparation method and mask prepared based on same
CN114680128B (en) Antimicrobial aqueous solution and preparation method and application thereof
CN111202101A (en) Anti-fogging disposable mask preparation liquid and preparation method thereof
CN112538666A (en) Reusable nano-fiber film for antibacterial biological protective mask and manufacturing method thereof
CN111155177B (en) Electrostatic spinning antiviral thin layer and application thereof in antiviral field
CN114606767B (en) Preparation method of broad-spectrum antibacterial polypropylene non-woven fabric
CN115559121B (en) Preparation method of antibacterial goose down

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
AD01 Patent right deemed abandoned

Effective date of abandoning: 20230714